Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients: a randomized controlled trial (ETECAR-HD).

Trials · 2019 · PMC6813957 · PMID 31651370

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

They were able to show that a reduction in FGF23 of ≥ 30% after 20 weeks of therapy showed a trend towards a decrease in cardiovascular mortality, sudden cardiac death and heart failure [ 35 , 57 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.